Literature DB >> 30419113

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences.

Ann Marie Navar1, Tracy Y Wang1, Xiaojuan Mi1, Jennifer G Robinson2, Salim S Virani3, Veronique L Roger4, Peter W F Wilson5, Anne C Goldberg6, Eric D Peterson1.   

Abstract

Importance: Practice guidelines recommend that clinicians engage patients in treatment decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not describe how to communicate this risk most effectively. Objective: To determine how the ASCVD risk time horizon, outcome, and presentation format influence risk perceptions and treatment preferences. Design, Setting, and Participants: From May 27, 2015, through November 12, 2015, participants from the Patient and Provider Assessment of Lipid Management Registry at 140 US cardiology, primary care, and endocrinology practices were presented 3 independent scenarios (representing the same hypothetical patient) and asked to rate their perceived risk and willingness to take medication to lower risk in light of (1) a 15% 10-year ASCVD event risk, (2) a 4% 10-year cardiovascular disease (CVD) death risk, and (3) a 50% lifetime ASCVD event risk. Exposures: Participants were randomized to receive risk estimates using numbers only, a bar graph, or a face pictogram.
Results: Of 3566 eligible participants, 2708 (76.9%) responded (median age, 67 years [interquartile range, 61-76 years]; 280 [10.3%] African American; 1491 men [55.1%]). When shown the lifetime ASCVD risk, respondents were more likely to consider the risk "high to very high" than when presented the 10-year ASCVD risk or the CVD death risk (70.1% vs 31.4% vs 25.7%, respectively; both P < .001). Treatment willingness was also the highest for lifetime ASCVD risk (77.9% very willing) followed by 10-year ASCVD risk (68.1%) and 10-year CVD death risk (63.1%; both P < .001). Compared with participants who were shown a bar graph or no graphic, those who were shown the risk information with a pictogram had the lowest perception of disease severity and the lowest willingness to consider therapy. These findings were robust across demographic and socioeconomic subgroups. Conclusions and Relevance: The format, time horizon, and outcome used for risk estimation influence patient perceptions and should be considered when designing risk communication tools. When shown lifetime risk estimates, patients had higher risk perception and willingness for therapy than when shown 10-year estimates. Pictogram risk displays may decrease risk perception and consideration for treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30419113      PMCID: PMC6551302          DOI: 10.1001/jamacardio.2018.3680

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  16 in total

Review 1.  Evidence-based risk communication: a systematic review.

Authors:  Daniella A Zipkin; Craig A Umscheid; Nancy L Keating; Elizabeth Allen; KoKo Aung; Rebecca Beyth; Scott Kaatz; Devin M Mann; Jeremy B Sussman; Deborah Korenstein; Connie Schardt; Avishek Nagi; Richard Sloane; David A Feldstein
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

Review 2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

Review 3.  Risk scoring for the primary prevention of cardiovascular disease.

Authors:  Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

4.  Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial.

Authors:  Adrian Edwards; Richard Thomas; Rhys Williams; Andrew L Ellner; Polly Brown; Glyn Elwyn
Journal:  Patient Educ Couns       Date:  2006-07-24

5.  Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care.

Authors:  Marije S Koelewijn-van Loon; Trudy van der Weijden; Gaby Ronda; Ben van Steenkiste; Bjorn Winkens; Glyn Elwyn; Richard Grol
Journal:  Prev Med       Date:  2009-11-26       Impact factor: 4.018

6.  Patients prefer pictures to numbers to express cardiovascular benefit from treatment.

Authors:  Felicity Goodyear-Smith; Bruce Arroll; Lydia Chan; Rod Jackson; Sue Wells; Timothy Kenealy
Journal:  Ann Fam Med       Date:  2008 May-Jun       Impact factor: 5.166

7.  Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial.

Authors:  Tanja Krones; Heidemarie Keller; Andreas Sönnichsen; Eva-Maria Sadowski; Erika Baum; Karl Wegscheider; Justine Rochon; Norbert Donner-Banzhoff
Journal:  Ann Fam Med       Date:  2008 May-Jun       Impact factor: 5.166

8.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01

9.  Measuring numeracy without a math test: development of the Subjective Numeracy Scale.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel; Aleksandra Jankovic; Holly A Derry; Dylan M Smith
Journal:  Med Decis Making       Date:  2007-07-19       Impact factor: 2.583

10.  Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry.

Authors:  Ann Marie Navar; Tracy Y Wang; Anne C Goldberg; Jennifer G Robinson; Veronique L Roger; Peter F Wilson; Salim S Virani; Joesph Elassal; L Veronica Lee; Laura E Webb; Eric Peterson
Journal:  Am Heart J       Date:  2015-08-07       Impact factor: 4.749

View more
  14 in total

1.  Association of ideal cardiovascular health with cardiovascular events and risk advancement periods in a Mediterranean population-based cohort.

Authors:  Cesar I Fernandez-Lazaro; Carmen Sayon-Orea; Estefania Toledo; Conchi Moreno-Iribas; María J Guembe
Journal:  BMC Med       Date:  2022-07-05       Impact factor: 11.150

2.  Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.

Authors:  Ramachandran S Vasan; Danielle M Enserro; Vanessa Xanthakis; Alexa S Beiser; Sudha Seshadri
Journal:  Circulation       Date:  2022-04-18       Impact factor: 39.918

3.  A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease.

Authors:  Aparna Sajja; Hsin-Fang Li; Kateri J Spinelli; Amir Ali; Salim S Virani; Seth S Martin; Ty J Gluckman
Journal:  Am J Prev Cardiol       Date:  2021-04-27

4.  Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.

Authors:  Laila Staerk; Sarah R Preis; Honghuang Lin; Juan P Casas; Kathryn Lunetta; Lu-Chen Weng; Christopher D Anderson; Patrick T Ellinor; Steven A Lubitz; Emelia J Benjamin; Ludovic Trinquart
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-31

5.  Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.

Authors:  Ann Marie Navar; Tracy Y Wang; Shuang Li; Xiaojuan Mi; Zhuokai Li; Jennifer G Robinson; Salim S Virani; Eric D Peterson
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-01-13

6.  Perceptions of Patients with Primary Nonadherence to Statin Medications.

Authors:  Derjung M Tarn; Maureen Barrientos; Mark J Pletcher; Keith Cox; Jon Turner; Alicia Fernandez; Janice B Schwartz
Journal:  J Am Board Fam Med       Date:  2021 Jan-Feb       Impact factor: 2.657

7.  Lifetime Risk of Heart Failure Among Participants in the Framingham Study.

Authors:  Ramachandran S Vasan; Danielle M Enserro; Alexa S Beiser; Vanessa Xanthakis
Journal:  J Am Coll Cardiol       Date:  2022-01-25       Impact factor: 24.094

8.  Show Me the Money: Patients' Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost.

Authors:  Neal W Dickert; Andrea R Mitchell; Grace E Venechuk; Daniel D Matlock; Miranda A Moore; Alanna A Morris; Kenneth J Pierce; Candace D Speight; Larry A Allen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-12-11

9.  Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.

Authors:  Sarah T Ahmed; Julia M Akeroyd; Dhruv Mahtta; Richard Street; Jason Slagle; Ann Marie Navar; Neil J Stone; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  J Am Heart Assoc       Date:  2020-11-10       Impact factor: 5.501

10.  Perceptions of recurrence risk and behavioural changes among first-ever and recurrent stroke survivors: A qualitative analysis.

Authors:  Beilei Lin; Zhenxiang Zhang; Yunfei Guo; Wenna Wang; Yongxia Mei; Shanshan Wang; Yao Tong; Nazia Shuaib; Daphne Cheung
Journal:  Health Expect       Date:  2021-08-06       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.